Skip to content

Erector Spinae Plane Blocks (ESP) for Postoperative Pain in Lumbo-sacral Spine Surgery

Bilateral Erector Spinae Plane Blocks (ESP) for Postoperative Pain in Lumbo-sacral Spine Surgery: A Double-blinded Randomized Controlled Trial

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04233736
Enrollment
0
Registered
2020-01-18
Start date
2021-07-01
Completion date
2022-01-01
Last updated
2026-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erector Spinae Plane Block, Lumbar Spine Surgery

Brief summary

The goal of this study is to evaluate the analgesic efficacy of bilateral erector spinae plane (ESP) blocks after lumbar and lumbo-sacral spine surgery by assessing postoperative pain scores and opiate requirements as the primary outcome measures. We are aiming to investigate how ESP blocks, performed under ultrasound guidance at the T12 vertebral level, contribute to postoperative pain control. This will be determined by measuring numerical rating pain scores repeatedly following surgery and opiate consumption until patient discharge from hospital. These primary outcome measures will be compared between a treatment group of participants, who will receive ESP blocks and a control group who will receive a sham block. Our primary hypothesis is that ESP blocks significantly reduce postoperative pain and opiate requirements

Interventions

PROCEDUREBilateral lumbar erector spinae plane block

Bilateral lumbar erector spinae plane blocks performed under ultrasound guidance

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Spine surgery at or below the L1 vertebral level * Midline surgical approach

Exclusion criteria

* Previous lumbar or lumbo-sacral surgery with or without hardware placement * Evidence of dura pathology (including CSF leak) * Spine tumor * Non-English speaking

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain scoresDuring hospitalization, typically lasting between 1 and 5 daysPain scores will be measured and documented as part of routine clinical care using the standard NRS (numerical rating scale, ranging from 0= no pain to 10= worst imaginable pain). Pain assessments will be made several times per day starting pre-operatively and continued during hospitalization.
Perioperative opiate consumptionDuring hospitalization, typically lasting between 1 and 5 daysPeri-operative opiate consumption will be assessed by measuring opiate administration intra- and post-operatively (during hospitalization) and expressed as oral morphine equivalents (OMEs).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORClaas Siegmueller, MD PhD MBA

University of California, San Francisco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 2, 2026